Why is Akums Drugs falling/rising?

As of 10-Nov, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 439.70, reflecting a decrease of Rs 14.75 or 3.25%. The stock has underperformed its sector by 4.3% today and has been on a consecutive downward trend for the last three days, with a total decline of 6.63% during this period. The stock has also touched an intraday low of Rs 436, indicating significant selling pressure. Over the past year, the stock has generated a return of -44.83%, which is considerably worse than the benchmark Sensex, which has gained 5.09%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a price-to-book value of 2.3, the company has shown poor long-term growth, with net sales growing at only 6.10% annually over the last five years.
Broader market context indicates that while the Sensex has shown a slight decline of 0.53% over the past week, Akums Drugs has dropped significantly by 6.10% in the same timeframe. The stock's performance is further hindered by a decrease in institutional investor participation, which has fallen by 1.54% in the last quarter, suggesting a lack of confidence among more knowledgeable investors. Additionally, the company's recent financial results have been disappointing, with a notable decline in profit after tax and operating profit, which has contributed to the negative sentiment surrounding the stock. Overall, the combination of poor recent performance, declining institutional interest, and lackluster growth prospects has led to the stock's downward trajectory.